MediFind Gains Digital Medicine Society Seal, Bolstering Trust in Provider Directories

Event summary

  • MediFind, a provider directory owned by Phreesia, received the Digital Medicine Society (DiMe) Seal on April 9, 2026.
  • The DiMe Seal assesses digital health platforms based on clinical evidence, privacy/security, and usability.
  • Phreesia acquired MediFind in July 2023.
  • MediFind utilizes data science and AI to connect patients with specialists, particularly for rare and chronic conditions.

The big picture

The DiMe Seal represents a growing emphasis on transparency and validation within the digital health sector, driven by increasing patient scrutiny and regulatory considerations. As online healthcare resources proliferate, independent verification mechanisms like the DiMe Seal are becoming crucial for establishing credibility and attracting users. Phreesia’s acquisition of MediFind and its subsequent validation underscores the importance of data-driven solutions in navigating the complexities of patient care and building trust in digital health tools.

What we're watching

Adoption Rate
The DiMe Seal's impact will depend on its adoption by both patients and providers; widespread recognition is needed for it to meaningfully influence platform selection.
Competitive Response
Other provider directories will likely face pressure to pursue similar certifications, potentially leading to a commoditization of trust signals within the space.
Phreesia Integration
The extent to which MediFind’s data science capabilities are integrated into Phreesia’s broader patient activation platform will determine the overall strategic value of the acquisition.